Should universal hepatitis B immunisation be introduced in the UK?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. Anti-cancer vaccines - a one-hit wonder?The Yale journal of biology and medicine · 2014
   Review
2. Hepatitis B virus: where do we stand and what is the next step for eradication?World journal of gastroenterology · 2014
   Review
3. The third immigrant disease.Clinical medicine (London, England) · 2013
   Article
4. Gastroenterology in developing countries: issues and advances.World journal of gastroenterology · 2009
   Review
5. Hepatitis B immunization strategies: timing is everything.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2009
   Review
6. Childhood immunisation: what is the future?Archives of disease in childhood · 2007
   Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as